Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 662 results for "glenmark pharmaceuticals"

SC stays Delhi HC order restraining Glenmark from making anti-diabetes drug

SC stays HC order restraining firm from manufacturing anti-dia...

The Supreme Court on Wednesday stayed a Delhi High Court order restraining Indian pharma company Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met for allegedly infringing the patent rights of US drug major ... Times of India, 6 days ago

11 images for glenmark pharmaceuticals

IndiaPost, 1 week ago
PR Newswire, 1 month ago, 1 week ago, 1 month ago
India Infoline, 1 month ago
India Infoline, 2 months ago
Business Today India, 4 months ago
Financial Express, 2 months ago
Money Control, 5 months ago
Sify, 3 months ago

Glenmark Pithampur Plant wins MPFCCI Outstanding Achievement Award 2014

Indore: Glenmark Generics Limited's Pithampur Plant near Indore was recently awarded the Outstanding Achievement Awards 2014 for excellence in Health & Safety by The Federation of Madhya Pradesh Chamber of Commerce and Industry (MPFCCI). The ...
 Central Chronicle6 days ago Glenmark's Pithampur plant bags award  New Delhi Pioneer1 week ago Glenmark's Pithampur Plant in Madhya Pradesh, India Wins MPFCCI Outstanding Achievement Award 2014 for Excellence in Health & Safety  Reliance Trust6 days ago
Business Standard

Cipla, Divis Labs, Glenmark to get astro support: Gupta

Pharma stocks like Strides Arcolab, Divis Laboratories, Glenmark Pharma, Dishman Pharma, Orchid Chemicals and Cipla will get astro support, says Satish Gupta of astrostocktips.
 Money Control1 week ago Lupin, Aurobindo Pharma, Cipla to get astro support: Gupta  Money Control2 weeks ago Pharma shares in demand; CNX Pharma index hits record high  Business Standard1 month ago Mixed Q3 nos for pharma so far: Here's what you should buy  Money Control1 month ago

Retain buy on Glenmark, target Rs 790: Nomura

We retain buy on Glenmark Pharmaceuticals and value the stock on a sum-of-the-parts basis to reach our target price of R790. We arrive at core business one-year-forward fair value of R707 per share, based on 18x one-year forward EPS of R39.3 ...
 Financial Express1 week ago
India Infoline

Glenmark Pharmaceuticals updates on scheme of amalgamation

This page uses frames, but your browser doesn't
 Capital Market1 week ago Glenmark receives approval for Salmecort MDI inhaler from MoH Russia  Individual.com1 week ago Top corporate news of the day - March 13, 2015  India Infoline2 weeks ago Glenmark gets nod from Russia for Salmecort MDI inhaler  ZeeNews.com2 weeks ago

Court restrains Glenmark from making/selling its version of Merck's diabetes medicines

Close to two years after Merck and Glenmark locked horns over diabetes drugs Januvia and Janumet, the Delhi High Court has restrained Glenmark from making and marketing its versions of the drug. While Merck Sharp & Dohme (MSD) expressed its ...
 Hindu Business Line1 week ago
India Infoline

AIA Engineering, Bosch, Glenmark Pharma among 52 stocks which hit 52-week high

A total of 16 stocks touched a fresh 52-week high on BSE today. Prominent among these were — AIA Engineering, Bosch, Glenmark Pharma, Hitachi Home, Kalyani Investment Company, Kaveri Seed, Marico Kaya, Page Industries, Pidilite Industries, Pioneer ...
 India Infoline1 week ago
IBNLive India News

Glenmark Pharma gains on talk of positive announcement

Glenmark Pharmaceuticals gained as much as 4.48 per cent in intraday trade on Thursday and closed up 3.53 per cent or Rs 29.10. The stock surged mainly as there is speculation that company may call press conference on Friday to announce a positive ...
 Economic Times1 week ago Budget boost for healthcare sector pushes pharma shares up 5 per cent  IBNLive India News1 month ago
India Infoline

Glenmark Pharma stock closed 5% lower

According to media reports, the Delhi High Court (HC) on Friday restrained Glenmark from manufacturing, marketing and selling its anti-diabetes drugs Zita and Zita-Met, on 'prima-facie' findings that the company seems to have infringed the patent of US drug ...
 India Infoline1 week ago Glenmark Pharma stock down 3%  India Infoline1 week ago Tough time continues...Nifty closes below 8,600  India Infoline1 week ago Investors take refuge in pharma, FMCG as markets take a beating  Financial Express3 weeks ago

India's top court issues injunction on Glenmark from selling copy of Merck's Januvia

India's highest court has granted an injunction against Glenmark Pharmaceuticals, blocking it from producing and marketing a generic of Merck's ($MRK) Januvia (sitagliptin) for treating diabetes. A patent-infringement suit was not affected by the ...
 Fierce Drug Delivery1 week ago BRIEF-India's Glenmark Pharma says seeking legal advise on court injunction against selling Zita and Zita-Met  Reuters UK1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - glenmark pharmaceuticals
Get updated on latest news & your favorite topics right in your inbox!
More     Less